Related Experiment Video
Updated: Jun 2, 2026
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK
1Gochang-gun Public Health Center, Ministry of Health and Welfare, Go-Chang, Republic of Korea.
Insights
Clinically defined obesity and organ dysfunction trajectories improve cardiovascular risk prediction compared to BMI alone. Persistent organ dysfunction indicates the highest risk for major adverse cardiovascular events (MACE).
Area of Science:
- Cardiology
- Metabolic Disorders
- Public Health
Background:
- Obesity is a significant, modifiable risk factor for cardiovascular disease.
- Current risk assessment often relies on Body Mass Index (BMI) categories.
- The relationship between obesity, organ dysfunction, and cardiovascular events needs further clarification.
Purpose of the Study:
- To evaluate if multi-organ dysfunction trajectories improve cardiovascular risk discrimination compared to BMI-based obesity classifications.
- To assess the association between clinically defined obesity, organ dysfunction, and major adverse cardiovascular events (MACE).
Main Methods:
- Analysis of 457,675 UK Biobank participants using ethnicity-specific BMI thresholds.
- Classification of obesity into no, preclinical, or clinical obesity based on organ dysfunction.
- Construction of organ dysfunction trajectories (status and change) over 2-year periods.
- Follow-up for incident MACE (ischemic heart disease, stroke, fatal cardiovascular disease).
Main Results:
- Multi-organ dysfunction trajectories showed a graded increase in MACE risk, with persistent dysfunction posing the highest risk.
- Clinically defined obesity demonstrated a more monotonic, graded risk association with MACE compared to BMI categories.
- Underweight BMI categories showed higher risk in dysfunction trajectories than expected, suggesting reverse causation.
Conclusions:
- Multi-organ dysfunction trajectories are strongly linked to incident MACE.
- Clinically defined obesity, combined with longitudinal dysfunction assessment, offers improved cardiovascular risk stratification over BMI alone.
- This approach may enhance the identification of individuals at high risk for cardiovascular events.
Objective:
Obesity is a major modifiable risk factor for cardiovascular disease. We evaluated whether multi-organ dysfunction trajectories for major adverse cardiovascular events (MACE) using clinically defined obesity classification improves risk discrimination compared with BMI-based categories.
Methods:
We analyzed 457,675 UK Biobank participants. BMI-based categories were defined using ethnicity-specific thresholds. Clinically defined obesity was classified as no, preclinical (excess adiposity without organ dysfunction), or clinical obesity (excess adiposity with ≥1 obesity-related organ dysfunction). Organ dysfunction trajectories were constructed over consecutive 2-year periods beginning 2 years after baseline: (1) status (no, period 1 only, period 2 only, persistent organ dysfunctions) and (2) change (no, increase, decrease, persistent organ dysfunctions). Incident MACE was defined as a composite of ischemic heart disease, stroke, and fatal cardiovascular disease. Participants were followed until the first occurrence of incident MACE, death, 10 years after the index date, or the end of follow up, whichever came first. Cox models estimated adjusted hazard ratio (aHR).
Results:
Across status trajectories, MACE risk increased in a graded response from no dysfunction to persistent dysfunction under both obesity definitions. Within trajectories, clinical obesity showed the highest risk under the clinically defined definition (clinical vs no obesity: no dysfunction aHR 2.03, 95% CI 1.96-2.11; persistent dysfunction aHR 1.61, 95% CI 1.30-2.01), whereas underweight showed the highest risk under BMI categories (underweight vs normal: no dysfunction aHR 1.83, 95% CI 1.62-2.07; persistent dysfunction aHR 2.19, 95% CI 1.32-3.63). The 10-year cumulative incidence of MACE within persistent dysfunction increased monotonically across clinically defined categories (~24% in clinical obesity), while BMI-based categories peaked in the overweight (~20%).
Conclusions:
Multi-organ dysfunction trajectories were strongly associated with incident MACE, having persistent dysfunction as the highest risk. Clinically defined obesity provided more monotonic, graded risk across trajectories than BMI, which were susceptible to reverse causation. Incorporating clinical obesity definitions with longitudinal dysfunction assessment may improve cardiovascular risk stratification.
Related Concept Videos
01:24Obesity
01:21Drug Dosing: Obese Patients
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Coronary Artery Disease I: Introduction